- Company name
- JBS
- Sector
- Meat and food products
- About
- JBS N.V. (JBS) is a public limited liability company of the Netherlands with its main operations in Brazil and the United States. It is the largest protein company in the world by net revenue, which was $86.2 billion in 2025. It processes beef, chicken, pork, fish and lamb and makes prepared foods, and it sells to more than 330,000 customers in about 197 countries. Its segments are JBS Brazil, Seara, JBS Beef North America, JBS USA Pork, Pilgrim's Pride, of which it owns about 82.1%, and JBS Australia. Its ultimate controlling shareholders, through J&F, held 85.68% of the voting power at March 18, 2026, because each Class B share has ten votes. The Class A shares trade on the NYSE in US dollars, and Brazilian depositary receipts trade on B3. From the quarter ended June 30, 2026, JBS files 10-Q and 8-K reports, as a US company does, with financial statements in IFRS.
- Thesis
- The price of JBS depends on the cattle cycle in the United States, on its high debt and on its controlling shareholder. Adjusted EBITDA fell 36% in 3Q26 to $1,181 million, and net debt rose to 3.54 times Adjusted EBITDA, because US beef margins were weak, pork prices fell, and exports from Brazil to China fell when the 2026 quota was full. The market also discounts the purchases from J&F, such as Flora and Canal Rural, which JBS pays for with new shares. For the price to rise toward the AI estimate, three things must be true. US beef margins must stay positive, as they were in September 2026. Leverage must fall back toward 2.5 times through 2027. The proposed purchase of the PPC minority shares and the deals with J&F must not reduce the value of each share. The 4Q26 report, expected in early 2027, the first results under the new Global CEO, Wesley Batista Filho, from January 2027, and the China quota for 2027 are the next tests.
- Valuation
- The intrinsic value for JBS is an AI estimate from November 14, 2026. It is not an analyst's value. An AI research agent calculated it from the filings of JBS N.V. with the SEC, which it makes in IFRS. The pick is the Class A common share on the NYSE. Class B shares have ten votes each, but JBS counts both classes together in its earnings per share, so the estimate counts them as one. The method is a multiple of 2027 Adjusted EBITDA (IFRS), less net debt and lease liabilities, divided by the shares plus the shares that the proposed purchase of the minority shares of Pilgrim's Pride Corporation (PPC) would issue. The 2025 Form 20-F gives Adjusted EBITDA of $6,831.4 million for 2025, $7,191.9 million for 2024 and $3,457.9 million for 2023. The 3Q26 release (8-K, November 9, 2026) gives net sales of $22,738 million and Adjusted EBITDA of $1,181 million for 3Q26, and Adjusted EBITDA of $3,744 million for nine months against $5,116 million a year earlier, so Adjusted EBITDA for the 12 months to September 30, 2026 was $5,459.4 million. It gives net debt of $19,304.9 million, or 3.54 times. The Form 10-Q for the quarter ended September 30, 2026 gives lease liabilities of $1,859.1 million, and its cover gives 777,017,145 Class A shares and 294,842,267 Class B shares at September 30, 2026. JBS owns about 82.1% of PPC, which had 238,112,010 shares at September 27, 2026 (PPC Form 10-Q), and on August 18, 2026 JBS proposed 2.086 Class A shares for each PPC share that it does not own. The estimate counts the PPC minority as the 88.9 million Class A shares of this proposal, so it uses 1,160.8 million shares, which is an assumption. It also assumes that the planned purchases of Flora and Canal Rural for Class A shares add as much value as the shares they issue. The 2027 Adjusted EBITDA and the multiples are assumptions. The low case assumes $5,000 million, because cattle stay scarce in the United States and pork and chicken margins fall, at 5.5 times. It gives $5.46 per share. The base case assumes $6,000 million, a partial recovery from the last 12 months toward the levels of 2024 and 2025, at 6.5 times. It gives $15.37 per share. The high case assumes $7,000 million, from a full recovery in US beef margins, at 7.5 times. It gives $27.00 per share. The estimate assumes weights of 25%, 50% and 25%. The weighted intrinsic value is $15.80 per share. JBS is the largest protein company in the world by net revenue, with large plants on several continents, but beef, chicken and pork are commodities, and cattle and feed costs move in cycles that JBS does not control.
As of Nov 14, 2026.
- Risks
- Net debt was $19,304.9 million at September 30, 2026, or 3.54 times Adjusted EBITDA, against 2.39 times a year earlier. A long period of weak cattle margins can keep leverage high.
The controlling shareholders held 85.68% of the voting power at March 18, 2026, and JBS buys companies from J&F, such as Flora and Canal Rural, with new shares. Minority shareholders have little influence on these decisions.
Quotas and trade limits can close markets. In 3Q26, exports from Brazil to China fell after the 2026 quota was full, and quotas in China and South Korea also limited exports from Australia.
JBS USA pays antitrust settlements in the United States. Adjusted net income for the first nine months of 2026 leaves out $157.8 million for antitrust agreements.
Animal diseases, such as avian influenza, weather and higher costs from conflicts in the Middle East can reduce supply, raise costs or close export markets.
- Balance sheet
- Cash: $4.1B
Debt: $23.6B
Net debt: $19.3B
Net debt / EBITDA: 3.5× (medium)
Debt due within 12 months: $1.4B
At September 30, 2026, JBS had cash and cash equivalents of $4,148.8 million. Gross debt was $23,608.4 million, of which $1,421.4 million was due within 12 months, and net debt was $19,304.9 million, or 3.54 times Adjusted EBITDA of the last 12 months. Lease liabilities were $1,859.1 million. Equity attributable to company shareholders was $8,331.0 million, and non-controlling interests were $846.0 million. In the first nine months of 2026, JBS paid dividends of $1,070.9 million.
As of Sep 30, 2026.
- Checkpoints
- Dec 2026 (estimate): Closing of the Flora and Canal Rural purchases. Pending. Watch: The deals close on the agreed terms without more related-party deals, and this passes; higher prices or new purchases from J&F fail.
Feb 9, 2027 (estimate): 4Q26 results. Pending. Watch: Adjusted EBITDA (IFRS) for 4Q26 is higher than the $1,181 million of 3Q26 and leverage falls below 3.54 times, and this passes; lower EBITDA or higher leverage fails.
Q2 2027 (estimate): Decision on the PPC proposal. Pending. Watch: JBS and the PPC special committee agree on terms near 2.086 Class A shares for each PPC share that the PPC minority shareholders approve, and this passes; a much higher ratio fails.
- Recent events
- Nov 9, 2026: JBS reported 3Q26 net sales of $22,738 million, up 1%, Adjusted EBITDA (IFRS) of $1,181 million, down 36%, and EPS of $0.15. Net debt was $19,304.9 million, or 3.54 times Adjusted EBITDA.
Nov 9, 2026: JBS agreed to buy Flora, a Brazilian consumer products company, for R$2.968 billion and Canal Rural for R$88.1 million from J&F, its controlling shareholder, and to pay with Class A shares at R$66.82916 each. It expects both deals to close in December 2026.
Sep 23, 2026: Pilgrim's Pride issued $567.2 million of 4.750% senior notes due January 2034, partly to pay for Walkers Deli & Sausage Company in the United Kingdom.
Sep 15, 2026: JBS S.A. agreed with VIVA Holding to combine leather assets in JBS Viva, which each party will own 50%, subject to approval by CADE.
Aug 18, 2026: JBS proposed to buy all shares of Pilgrim's Pride that it does not own for 2.086 JBS Class A shares each. A special committee of independent PPC directors reviews the proposal.
Aug 10, 2026: JBS reported 2Q26 net sales of $23,900 million, up 14%, Adjusted EBITDA of $1,429 million, down 19%, and a net loss attributable to JBS of $102 million. It also said that Wesley Batista Filho will become Global CEO in January 2027 after Gilberto Tomazoni.
May 12, 2026: JBS said that it will file 10-Q, 10-K and 8-K reports as a US company does, from the quarter ended June 30, 2026, and publish its results sooner.
Mar 25, 2026: JBS reported 2025 net sales of $86,184 million, Adjusted EBITDA of $6,831 million and net income attributable to JBS of $2,024 million, or $1.89 per share.